1
TEVA PHARMACEUTICAL INDS LTD
SPONSORED ADS
SPONSORED ADS
1,500,082
$50.8m7.27%
7.27%
Added Shares held: Q3 2025 1.5m, Q4 2025 1.1m, Q1 2026 1.1m, Q2 2026 1.5m
+363.1k
+363,107
31.9%
2
MINERALYS THERAPEUTICS INC
COM
MLYS
MLYS
1,469,971
$39.7m5.68%
5.68%
Added Shares held: Q3 2025 219.9k, Q4 2025 449.0k, Q1 2026 1.3m, Q2 2026 1.5m
+130.0k
+130,000
9.7%
3
TOWER SEMICONDUCTOR LTD
SHS NEW
TSEM
TSEM
108,265
$28.2m4.04%
4.04%
Reduced Shares held: Q3 2025 311.8k, Q4 2025 122.5k, Q1 2026 145.7k, Q2 2026 108.3k
-37.5k
-37,470
-25.7%
4
SYNDAX PHARMACEUTICALS INC
COM
SNDX
SNDX
1,014,606
$22.2m3.17%
3.17%
Added Shares held: Q3 2025 387.7k, Q4 2025 762.6k, Q1 2026 724.6k, Q2 2026 1.0m
+290.0k
+290,043
40.0%
5
BIOGEN INC
COM
BIIB
BIIB
96,626
$20.9m2.99%
2.99%
Added Shares held: Q3 2025 82.7k, Q4 2025 94.7k, Q1 2026 92.5k, Q2 2026 96.6k
+4.1k
+4,100
4.4%
6
ULTRAGENYX PHARMACEUTICAL IN
COM
RARE
RARE
588,494
$19.6m2.81%
2.81%
Reduced Shares held: Q3 2025 352.6k, Q4 2025 300.6k, Q1 2026 809.3k, Q2 2026 588.5k
-220.8k
-220,839
-27.3%
7
BIOMARIN PHARMACEUTICAL INC
COM
BMRN
BMRN
328,550
$18.8m2.69%
2.69%
Added Shares held: Q3 2025 0, Q4 2025 147.0k, Q1 2026 139.9k, Q2 2026 328.6k
+188.7k
+188,650
134.8%
8
CYTOKINETICS INC
COM NEW
CYTK
CYTK
219,987
$18.7m2.68%
2.68%
Added Shares held: Q3 2025 161.5k, Q4 2025 91.7k, Q1 2026 39.8k, Q2 2026 220.0k
+180.2k
+180,170
452.5%
9
BRIDGEBIO PHARMA INC
COM
BBIO
BBIO
245,346
$18.3m2.61%
2.61%
Added Shares held: Q3 2025 40.7k, Q4 2025 107.7k, Q1 2026 245.2k, Q2 2026 245.3k
+100
+100
0.0%
10
COGENT BIOSCIENCES INC
COM
COGT
COGT
459,340
$17.8m2.54%
2.54%
Added Shares held: Q3 2025 98.5k, Q4 2025 378.5k, Q1 2026 416.3k, Q2 2026 459.3k
+43.0k
+43,000
10.3%
11
NOVA LTD
COM
NVMI
NVMI
25,169
$13.7m1.96%
1.96%
Reduced Shares held: Q3 2025 43.9k, Q4 2025 47.8k, Q1 2026 53.4k, Q2 2026 25.2k
-28.2k
-28,197
-52.8%
12
INSMED INC
COM PAR $.01
INSM
INSM
118,800
$12.7m1.81%
1.81%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 118.8k
13
MAZE THERAPEUTICS INC
COM
MAZE
MAZE
417,564
$12.5m1.78%
1.78%
Added Shares held: Q3 2025 154.3k, Q4 2025 71.8k, Q1 2026 227.3k, Q2 2026 417.6k
+190.2k
+190,221
83.7%
14
ASTRAZENECA PLC
ORD
AZN
AZN
62,530
$11.9m1.70%
1.70%
Unchanged Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 62.5k, Q2 2026 62.5k
15
SANOFI
SPONSORED ADR
SNY
SNY
269,515
$11.5m1.65%
1.65%
Unchanged Shares held: Q3 2025 219.5k, Q4 2025 239.5k, Q1 2026 269.5k, Q2 2026 269.5k
16
CYBIN INC
COM NEW
COM NEW
1,620,753
$10.7m1.53%
1.53%
Added Shares held: Q3 2025 370.4k, Q4 2025 825.6k, Q1 2026 987.1k, Q2 2026 1.6m
+633.7k
+633,663
64.2%
17
ELI LILLY & CO
COM
LLY
LLY
8,040
$9.6m1.38%
1.38%
Reduced Shares held: Q3 2025 10.0k, Q4 2025 9.0k, Q1 2026 9.0k, Q2 2026 8.0k
-1.0k
-1,000
-11.1%
18
MADRIGAL PHARMACEUTICALS INC
COM
MDGL
MDGL
17,419
$9.4m1.34%
1.34%
Added Shares held: Q3 2025 0, Q4 2025 3.3k, Q1 2026 9.0k, Q2 2026 17.4k
+8.4k
+8,379
92.7%
19
TREVI THERAPEUTICS INC
COM
TRVI
TRVI
499,029
$9.3m1.33%
1.33%
Reduced Shares held: Q3 2025 644.0k, Q4 2025 598.5k, Q1 2026 574.0k, Q2 2026 499.0k
-75.0k
-75,000
-13.1%
20
ACADIA PHARMACEUTICALS INC
COM
ACAD
ACAD
356,534
$9.0m1.29%
1.29%
Added Shares held: Q3 2025 148.9k, Q4 2025 212.2k, Q1 2026 256.2k, Q2 2026 356.5k
+100.3k
+100,332
39.2%
21
CELLDEX THERAPEUTICS INC NEW
COM NEW
CLDX
CLDX
240,868
$9.0m1.28%
1.28%
Reduced Shares held: Q3 2025 207.8k, Q4 2025 239.8k, Q1 2026 243.6k, Q2 2026 240.9k
-2.7k
-2,707
-1.1%
22
RHYTHM PHARMACEUTICALS INC
COM
RYTM
RYTM
80,400
$8.9m1.28%
1.28%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 80.4k
23
ORIC PHARMACEUTICALS INC
COM
ORIC
ORIC
752,983
$8.2m1.17%
1.17%
Added Shares held: Q3 2025 431.7k, Q4 2025 1.0m, Q1 2026 537.6k, Q2 2026 753.0k
+215.4k
+215,355
40.1%
24
LAM RESEARCH CORP
COM NEW
LRCX
LRCX
18,470
$8.0m1.15%
1.15%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 18.5k
25
APPLIED MATLS INC
COM
AMAT
AMAT
11,040
$8.0m1.14%
1.14%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 11.0k
26
TANGO THERAPEUTICS INC
COM
TNGX
TNGX
254,250
$7.9m1.14%
1.14%
Reduced Shares held: Q3 2025 0, Q4 2025 544.6k, Q1 2026 343.6k, Q2 2026 254.2k
-89.3k
-89,313
-26.0%
27
NOVARTIS AG
SPONSORED ADR
NVS
NVS
50,000
$7.8m1.12%
1.12%
Added Shares held: Q3 2025 37.0k, Q4 2025 37.0k, Q1 2026 37.0k, Q2 2026 50.0k
+13.0k
+13,000
35.1%
28
SOLAREDGE TECHNOLOGIES INC
NOTE 2.250% 7/0
SEDG 2.25 07.01.29
SEDG 2.25 07.01.29
4,000,000
$7.7m1.11%
1.11%
Unchanged Shares held: Q3 2025 4.0m, Q4 2025 4.0m, Q1 2026 4.0m, Q2 2026 4.0m
29
VOR BIOPHARMA INC
COM NEW
VOR
VOR
416,417
$7.7m1.10%
1.10%
Added Shares held: Q3 2025 0, Q4 2025 410.4k, Q1 2026 321.9k, Q2 2026 416.4k
+94.5k
+94,500
29.4%
30
ABBVIE INC
COM
ABBV
ABBV
30,256
$7.6m1.09%
1.09%
Unchanged Shares held: Q3 2025 25.3k, Q4 2025 25.3k, Q1 2026 30.3k, Q2 2026 30.3k
31
MERCK & CO INC
COM
MRK
MRK
58,600
$7.5m1.08%
1.08%
Added Shares held: Q3 2025 48.6k, Q4 2025 48.6k, Q1 2026 48.6k, Q2 2026 58.6k
+10.0k
+10,000
20.6%
32
JOHNSON & JOHNSON
COM
JNJ
JNJ
28,831
$7.3m1.05%
1.05%
Unchanged Shares held: Q3 2025 40.8k, Q4 2025 35.8k, Q1 2026 28.8k, Q2 2026 28.8k
33
IDEAYA BIOSCIENCES INC
COM
IDYA
IDYA
196,408
$7.3m1.05%
1.05%
New Shares held: Q3 2025 100.0k, Q4 2025 0, Q1 2026 0, Q2 2026 196.4k
34
IMMATICS N.V
SHS
IMTX
IMTX
720,057
$7.3m1.04%
1.04%
Added Shares held: Q3 2025 583.1k, Q4 2025 861.1k, Q1 2026 696.1k, Q2 2026 720.1k
+24.0k
+23,952
3.4%
35
NUVECTIS PHARMA INC
COM
NVCT
NVCT
382,945
$7.0m1.01%
1.01%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 382.9k
36
PFIZER INC
COM
PFE
PFE
286,000
$6.9m0.99%
0.99%
Added Shares held: Q3 2025 86.0k, Q4 2025 86.0k, Q1 2026 186.0k, Q2 2026 286.0k
+100.0k
+100,000
53.8%
37
HARMONY BIOSCIENCES HLDGS IN
COM
HRMY
HRMY
176,663
$6.4m0.92%
0.92%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 176.7k
38
XENON PHARMACEUTICALS INC
COM
XENE
XENE
105,000
$6.3m0.91%
0.91%
Reduced Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 127.0k, Q2 2026 105.0k
-22.0k
-22,000
-17.3%
39
CLIMB BIO INC
COM
CLYM
CLYM
483,747
$6.3m0.90%
0.90%
Added Shares held: Q3 2025 434.8k, Q4 2025 932.2k, Q1 2026 419.2k, Q2 2026 483.7k
+64.5k
+64,500
15.4%
40
ZENAS BIOPHARMA INC
COM
ZBIO
ZBIO
230,834
$5.9m0.84%
0.84%
Added Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 214.3k, Q2 2026 230.8k
+16.5k
+16,500
7.7%
41
NOVO-NORDISK A S
ADR
NVO
NVO
120,677
$5.8m0.83%
0.83%
Unchanged Shares held: Q3 2025 105.7k, Q4 2025 115.7k, Q1 2026 120.7k, Q2 2026 120.7k
42
ENLIVEN THERAPEUTICS INC
COM
ELVN
ELVN
112,765
$5.7m0.82%
0.82%
Reduced Shares held: Q3 2025 166.8k, Q4 2025 226.8k, Q1 2026 153.3k, Q2 2026 112.8k
-40.5k
-40,500
-26.4%
43
PRELUDE THERAPEUTICS INC
COM
PRLD
PRLD
1,019,832
$5.4m0.78%
0.78%
Added Shares held: Q3 2025 0, Q4 2025 122.8k, Q1 2026 558.3k, Q2 2026 1.0m
+461.5k
+461,493
82.7%
44
GSK PLC
SPONSORED ADR
GSK
GSK
102,000
$5.3m0.77%
0.77%
Reduced Shares held: Q3 2025 122.0k, Q4 2025 122.0k, Q1 2026 122.0k, Q2 2026 102.0k
-20.0k
-20,000
-16.4%
45
FORTE BIOSCIENCES INC
COM NEW
FBRX
FBRX
249,693
$5.3m0.76%
0.76%
Added Shares held: Q3 2025 474.3k, Q4 2025 185.9k, Q1 2026 185.0k, Q2 2026 249.7k
+64.7k
+64,709
35.0%
46
BIOAGE LABS INC
COM
BIOA
BIOA
213,671
$5.2m0.75%
0.75%
Added Shares held: Q3 2025 0, Q4 2025 243.0k, Q1 2026 86.5k, Q2 2026 213.7k
+127.2k
+127,153
147.0%
47
SCHOLAR ROCK HLDG CORP
COM
SRRK
SRRK
94,265
$5.2m0.74%
0.74%
Unchanged Shares held: Q3 2025 0, Q4 2025 158.3k, Q1 2026 94.3k, Q2 2026 94.3k
48
SATELLOS BIOSCIENCE INC
COM
MSLE
MSLE
652,590
$5.1m0.73%
0.73%
Added Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 489.2k, Q2 2026 652.6k
+163.4k
+163,383
33.4%
49
PALISADE BIO INC
COM
PALI
PALI
2,257,106
$4.7m0.68%
0.68%
Added Shares held: Q3 2025 0, Q4 2025 184.1k, Q1 2026 1.7m, Q2 2026 2.3m
+523.6k
+523,635
30.2%
50
ELEDON PHARMACEUTICALS INC
COM
ELDN
ELDN
1,191,187
$4.7m0.67%
0.67%
Reduced Shares held: Q3 2025 1.3m, Q4 2025 2.1m, Q1 2026 1.8m, Q2 2026 1.2m
-580.9k
-580,944
-32.8%
51
VISTRA CORP
COM
VST
VST
29,450
$4.7m0.67%
0.67%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 29.4k
52
TALEN ENERGY CORP
COM
TLN
TLN
12,135
$4.7m0.67%
0.67%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 12.1k
53
SAVARA INC
COM
SVRA
SVRA
756,164
$4.7m0.67%
0.67%
Added Shares held: Q3 2025 1.4m, Q4 2025 1.2m, Q1 2026 739.2k, Q2 2026 756.2k
+17.0k
+17,000
2.3%
54
DISC MEDICINE INC
COM
IRON
IRON
63,538
$4.6m0.66%
0.66%
Added Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 53.5k, Q2 2026 63.5k
+10.0k
+10,000
18.7%
55
GLOBAL X FDS
CLOUD COMPUTNG
CLOU
CLOU
195,900
$4.5m0.64%
0.64%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 195.9k
56
DYNE THERAPEUTICS INC
COM
DYN
DYN
199,594
$4.4m0.63%
0.63%
Added Shares held: Q3 2025 426.5k, Q4 2025 392.9k, Q1 2026 160.6k, Q2 2026 199.6k
+39.0k
+39,000
24.3%
57
RELAY THERAPEUTICS INC
COM
RLAY
RLAY
233,836
$4.4m0.63%
0.63%
Reduced Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 408.4k, Q2 2026 233.8k
-174.6k
-174,600
-42.8%
58
AVALO THERAPEUTICS INC
COM NEW
AVTX
AVTX
232,294
$4.3m0.61%
0.61%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 232.3k
59
PROMIS NEUROSCIENCES INC
COM SHS
PMN
PMN
325,591
$4.3m0.61%
0.61%
Unchanged Shares held: Q3 2025 0, Q4 2025 11.8k, Q1 2026 325.6k, Q2 2026 325.6k
60
BIOCRYST PHARMACEUTICALS INC
COM
BCRX
BCRX
422,051
$4.2m0.60%
0.60%
Reduced Shares held: Q3 2025 0, Q4 2025 837.9k, Q1 2026 866.5k, Q2 2026 422.1k
-444.4k
-444,413
-51.3%
61
REVOLUTION MEDICINES INC
COM
RVMD
RVMD
22,400
$4.2m0.60%
0.60%
Reduced Shares held: Q3 2025 60.0k, Q4 2025 52.5k, Q1 2026 55.1k, Q2 2026 22.4k
-32.7k
-32,710
-59.4%
62
CABALETTA BIO INC
COM
CABA
CABA
1,329,012
$4.1m0.59%
0.59%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 1.3m
63
GENERATE BIOMEDICINES INC
COM SHS
GENB
GENB
245,000
$4.1m0.59%
0.59%
Added Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 185.0k, Q2 2026 245.0k
+60.0k
+60,000
32.4%
64
MEDIWOUND LTD
SHS NEW
MDWD
MDWD
273,192
$4.0m0.57%
0.57%
Unchanged Shares held: Q3 2025 185.3k, Q4 2025 230.3k, Q1 2026 273.2k, Q2 2026 273.2k
65
ALPHA COGNITION INC
COM NEW
ACOG
ACOG
545,816
$3.9m0.56%
0.56%
Reduced Shares held: Q3 2025 338.8k, Q4 2025 567.6k, Q1 2026 567.6k, Q2 2026 545.8k
-21.8k
-21,800
-3.8%
66
WAVE LIFE SCIENCES LTD
SHS
96663EUR
96663EUR
638,272
$3.7m0.53%
0.53%
Added Shares held: Q3 2025 50.0k, Q4 2025 408.2k, Q1 2026 548.3k, Q2 2026 638.3k
+90.0k
+90,000
16.4%
67
CORVUS PHARMACEUTICALS INC
COM
CRVS
CRVS
244,961
$3.7m0.52%
0.52%
Reduced Shares held: Q3 2025 407.7k, Q4 2025 407.7k, Q1 2026 248.0k, Q2 2026 245.0k
-3.0k
-3,000
-1.2%
68
OVID THERAPEUTICS INC
COM
OVID
OVID
1,353,000
$3.6m0.52%
0.52%
Reduced Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 1.6m, Q2 2026 1.4m
-269.8k
-269,828
-16.6%
69
BRIDGEBIO ONCOLOGY THERAPEUT
COM NEW
BBOT
BBOT
460,985
$3.5m0.50%
0.50%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 461.0k
70
CYTOMX THERAPEUTICS INC
COM
CTMX
CTMX
879,000
$3.3m0.47%
0.47%
Added Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 220.0k, Q2 2026 879.0k
+659.0k
+659,000
299.6%
71
PROQR THRAPEUTICS N V
SHS EURO
PRQR
PRQR
1,757,458
$3.3m0.47%
0.47%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 1.8m
72
ALNYLAM PHARMACEUTICALS INC
COM
ALNY
ALNY
10,800
$3.3m0.47%
0.47%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 10.8k
73
KURA ONCOLOGY INC
COM
KURA
KURA
295,039
$3.2m0.46%
0.46%
Reduced Shares held: Q3 2025 245.5k, Q4 2025 295.5k, Q1 2026 295.5k, Q2 2026 295.0k
-483
-483
-0.2%
74
KODIAK SCIENCES INC
COM
KOD
KOD
81,796
$3.2m0.46%
0.46%
Reduced Shares held: Q3 2025 0, Q4 2025 175.5k, Q1 2026 114.8k, Q2 2026 81.8k
-33.0k
-33,000
-28.8%
75
ORMAT TECHNOLOGIES INC
COM
ORA
ORA
28,015
$3.1m0.44%
0.44%
Reduced Shares held: Q3 2025 29.0k, Q4 2025 0, Q1 2026 68.2k, Q2 2026 28.0k
-40.2k
-40,235
-59.0%
76
CONTINEUM THERAPEUTICS INC
CL A
CTNM
CTNM
183,475
$3.0m0.43%
0.43%
Added Shares held: Q3 2025 0, Q4 2025 173.5k, Q1 2026 173.5k, Q2 2026 183.5k
+10.0k
+10,000
5.8%
77
LARIMAR THERAPEUTICS INC
COM
LRMR
LRMR
926,004
$2.8m0.40%
0.40%
New Shares held: Q3 2025 260.4k, Q4 2025 0, Q1 2026 0, Q2 2026 926.0k
78
IMMIX BIOPHARMA INC
COM
IMMX
IMMX
270,000
$2.8m0.40%
0.40%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 270.0k
79
AMGEN INC
COM
AMGN
AMGN
7,500
$2.7m0.39%
0.39%
Unchanged Shares held: Q3 2025 9.5k, Q4 2025 7.5k, Q1 2026 7.5k, Q2 2026 7.5k
80
BIOHAVEN LTD
COM
BHVN
BHVN
164,437
$2.4m0.35%
0.35%
Reduced Shares held: Q3 2025 91.2k, Q4 2025 0, Q1 2026 594.0k, Q2 2026 164.4k
-429.6k
-429,563
-72.3%
81
CONSTELLATION ENERGY CORP
COM
CEG
CEG
9,850
$2.4m0.35%
0.35%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 9.8k
82
VERASTEM INC
COM NEW
VSTM
VSTM
632,632
$2.4m0.35%
0.35%
Added Shares held: Q3 2025 78.3k, Q4 2025 343.7k, Q1 2026 343.7k, Q2 2026 632.6k
+289.0k
+288,954
84.1%
83
TENAX THERAPEUTICS INC
COM NEW
TENX
TENX
120,200
$1.7m0.25%
0.25%
Reduced Shares held: Q3 2025 0, Q4 2025 190.1k, Q1 2026 136.0k, Q2 2026 120.2k
-15.8k
-15,815
-11.6%
84
TAYSHA GENE THERAPIES INC
COM SHS
TSHA
TSHA
250,000
$1.7m0.24%
0.24%
New Shares held: Q3 2025 408.1k, Q4 2025 368.1k, Q1 2026 0, Q2 2026 250.0k
85
STRUCTURE THERAPEUTICS INC
SPONSORED ADS
GPCR
GPCR
28,600
$1.5m0.22%
0.22%
Reduced Shares held: Q3 2025 173.9k, Q4 2025 41.0k, Q1 2026 50.8k, Q2 2026 28.6k
-22.2k
-22,200
-43.7%
86
UPSTREAM BIO INC
COM
UPB
UPB
219,700
$1.5m0.22%
0.22%
Reduced Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 358.0k, Q2 2026 219.7k
-138.3k
-138,300
-38.6%
87
VOYAGER THERAPEUTICS INC
COM
VYGR
VYGR
427,554
$1.5m0.21%
0.21%
Reduced Shares held: Q3 2025 199.8k, Q4 2025 339.8k, Q1 2026 469.8k, Q2 2026 427.6k
-42.2k
-42,207
-9.0%
88
ORGANOGENESIS HLDGS INC
COM
ORGO
ORGO
550,000
$1.3m0.19%
0.19%
Unchanged Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 550.0k, Q2 2026 550.0k
89
INHIBIKASE THERAPEUTICS INC
COM NEW
IKT
IKT
649,309
$1.3m0.19%
0.19%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 649.3k
90
CURIS INC
COM
COM
98,996
$1.0m0.15%
0.15%
Reduced Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 2.0m, Q2 2026 99.0k
-1.9m
-1,895,941
-95.0%
91
SHATTUCK LABS INC
COM
STTK
STTK
86,461
$600.0k0.09%
0.09%
Reduced Shares held: Q3 2025 0, Q4 2025 195.2k, Q1 2026 280.8k, Q2 2026 86.5k
-194.3k
-194,325
-69.2%
92
FIRST TRACKS BIOTHERAPEUTICS
ORD SHS
TRAX
TRAX
27,876
$560.9k0.08%
0.08%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 27.9k
93
SKYE BIOSCIENCE INC
COM NEW
COM NEW
678,928
$470.7k0.07%
0.07%
Unchanged Shares held: Q3 2025 478.9k, Q4 2025 478.9k, Q1 2026 678.9k, Q2 2026 678.9k
94
TRAWS PHARMA INC
COM NEW
TRAW
TRAW
398,486
$336.0k0.05%
0.05%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 398.5k
95
EVOMMUNE INC
COM SHS
EVMN
EVMN
22,632
$300.8k0.04%
0.04%
Reduced Shares held: Q3 2025 0, Q4 2025 166.1k, Q1 2026 78.2k, Q2 2026 22.6k
-55.6k
-55,602
-71.1%
96
WEREWOLF THERAPEUTICS INC
COM
HOWL
HOWL
626,810
$225.6k0.03%
0.03%
Unchanged Shares held: Q3 2025 626.8k, Q4 2025 626.8k, Q1 2026 626.8k, Q2 2026 626.8k
97
APREA THERAPEUTICS INC
COM NEW
APRE
APRE
270,000
$216.6k0.03%
0.03%
Unchanged Shares held: Q3 2025 270.0k, Q4 2025 270.0k, Q1 2026 270.0k, Q2 2026 270.0k